Impact of (68)Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician’s Perspective

Somatostatin receptor imaging with (68)Ga-DOTATATE PET/CT (DOTATATE) is increasingly used for managing patients with neuroendocrine tumors. The objective of this study was to determine referring physicians’ perspectives on the impact of DOTATATE on the management of neuroendocrine tumors. METHODS: A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Nucl Med
Autors principals: Herrmann, Ken, Czernin, Johannes, Wolin, Edward M., Gupta, Pawan, Barrio, Martin, Gutierrez, Antonio, Schiepers, Christiaan, Mosessian, Sherly, Phelps, Michael E., Allen-Auerbach, Martin S.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5068919/
https://ncbi.nlm.nih.gov/pubmed/25500825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.114.148247
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars